Antonio Liras
Professor of Biochemistry and Molecular Biology at the Complutense University of Madrid. He holds a degree in Chemical Sciences and a PhD in Pharmacy from the same university, and is a European Union Specialist in Clinical Analysis. He is a member of the Advisory Committee of the Spanish Federation of Rare Diseases (FEDER) and Director of the Research Group on Advanced, Gene and Cell Therapies for the Treatment of Congenital Coagulopathies. He also serves as Scientific Coordinator of the Association for Research and Cure of Factor V Deficiency.
He is a member of the editorial boards of several biomedical journals and an Academician of the Royal National Academy of Pharmacy of Spain. He has been principal investigator of numerous research projects in biomedical research and rare diseases and is the author of more than one hundred national and international publications, as well as several scientific and educational books and book chapters. He has been a speaker at numerous national and international conferences.
His extensive work in technology and knowledge transfer includes the exploitation of research results, patents, and contracts with pharmaceutical companies. He has also served as a reviewer and evaluator of research projects at both national and international levels. Among his achievements is the patent for the first viable mouse model of coagulation Factor V deficiency. He has received several research awards, including the ConfiHe Baxter Award, the Spanish Society of Thrombosis and Haemostasis Award, the Victoria Eugenia Royal Foundation Award, and the Royal National Academy of Pharmacy of Spain Award.
